최신 재무제표(Form-10K)에 따르면, Acutus Medical Inc의 총 자산은 $0이며, 순손실입니다.
AFIB의 주요 재무 비율은 무엇인가요?
Acutus Medical Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Acutus Medical Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Acutus Medical Inc 주요 수익원은 Disposables이며, 최신 수익 발표에서 수익은 19,629,000입니다. 지역별로는 United States이 Acutus Medical Inc의 주요 시장이며, 수익은 20,157,000입니다.
Acutus Medical Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Acutus Medical Inc의 순손실은 $0입니다.
Acutus Medical Inc에 부채가 있나요?
no, Acutus Medical Inc의 부채는 0입니다.
Acutus Medical Inc의 발행 주식은 몇 주인가요?
Acutus Medical Inc의 총 발행 주식은 0주입니다.
주요 통계
이전 종가
$0.0003
시가
$0.0003
일일 범위
$0.0003 - $0.0003
52주 범위
$0 - $0.045
거래량
--
평균 거래량
17.2K
배당수익률
--
EPS(TTM)
-0.32
시가총액
$8.9K
AFIB란 무엇인가요?
Acutus Medical, Inc. is an arrhythmia management company, which engages in improving the way cardiac arrhythmias are diagnosed and treated. The company is headquartered in Carlsbad, California and currently employs 85 full-time employees. The company went IPO on 2020-08-06. The firm is solely focused on supporting the manufacturing and distribution of products to Medtronic. The company manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (i.e., the Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.